Lars Bastholt

31.1k citations
183 papers · 8.3k · 4 hit papers · h-index 42

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Cutaneous Melanoma Detection and Management
    • CAR-T cell therapy research
    • Cancer-related Molecular Pathways

Papers in

    • Cancer Immunotherapy and Biomarkers 42
    • Cutaneous Melanoma Detection and Management 33
    • CAR-T cell therapy research 31
    • Cancer Treatment and Pharmacology 15
    • Melanoma and MAPK Pathways 29

Lars Bastholt

180 papers receiving 8.1k citations

Lars Bastholt's Hit Papers

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline 2015 · 340 citations
3400+7+15Years since publication2505007501000

Peers

Lars Bastholt
Comparison fields: 5 of 140
  • Otorhinolaryngology 1.1k
  • Oncology 4.2k
  • Endocrinology, Diabetes and Metabolism 2.4k
  • Pulmonary and Respiratory Medicine 1.7k
  • Immunology 1.1k
Replace Francis P. Worden with:
Francis P. Worden United States
Stephen Y. Lai United States
William H. Westra United States
Bhumsuk Keam South Korea
George Pentheroudakis Greece
Harold J. Wanebo United States
Lisa Licitra Italy
Erich M. Sturgis United States
Kate Newbold United Kingdom
John K. Chan United States
Lars Bastholt relative to Francis P. Worden United States Francis P. Worden's profile →
Citations per field
00.5×1.5×2.2×
Francis P. Worden · 1×
Citations per year

Countries citing papers authored by Lars Bastholt

Since Specialization
Citations

This map shows the geographic impact of Lars Bastholt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Bastholt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Bastholt more than expected).

Fields of papers citing papers by Lars Bastholt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Bastholt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Bastholt. The network helps show where Lars Bastholt may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Bastholt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Bastholt Line = papers co-authored together Lars Bastholt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Hit paper breakdown →
20141153
2
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
Hit paper breakdown →
2003481
3 2011443
4
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
Hit paper breakdown →
2015371
5 2008363
6
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
Hit paper breakdown →
2015340
7 2012280
8 2005268
9 2009257
10 2000221
11 2011218
12 1996135
13 1987122
14 1997121
15 2008103
16 1994100
17 2009100
18 199999
19 201293
20 200593

About Lars Bastholt

Lars Bastholt is a scholar working on Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Immunology and Pulmonary and Respiratory Medicine, having authored 183 papers that have together received 8.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (42 papers), Thyroid Cancer Diagnosis and Treatment (38 papers), Cutaneous Melanoma Detection and Management (33 papers), CAR-T cell therapy research (31 papers), Immunotherapy and Immune Responses (30 papers), Melanoma and MAPK Pathways (29 papers), Head and Neck Cancer Studies (18 papers) and Cancer Treatment and Pharmacology (15 papers). The work is most often cited by research in Otorhinolaryngology (1.1k citations), Oncology (4.2k citations), Endocrinology, Diabetes and Metabolism (2.4k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Immunology (1.1k citations). Lars Bastholt has collaborated with scholars based in Denmark, France and Germany. Frequent co-authors include Martin Schlumberger, Olfred Hansen, Steven I. Sherman, Lena Specht, Hanne Sand Hansen, Barbara Jarząb, Furio Pacini, Christelle de la Fouchardière, Rossella Elisei and Henrik Schmidt. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Acta Oncologica and Melanoma Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact